THE BASIC PRINCIPLES OF HEMGENIX

Number of suitable clients: CDEC talked about the uncertainty in the quantity of clients with moderately critical to extreme hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some people who're classified as having gentle or moderate disease could have a severe bleeding phenotype,